KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Moderna (MRNA) Other Gross PP&E Adjustments (2017 - 2025)

Historic Other Gross PP&E Adjustments for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $2.1 billion.

  • Moderna's Other Gross PP&E Adjustments fell 414.34% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 414.34%. This contributed to the annual value of $1.8 billion for FY2024, which is 1795.37% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Other Gross PP&E Adjustments is $2.1 billion, which was down 414.34% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Other Gross PP&E Adjustments registered a high of $2.3 billion during Q3 2023, and its lowest value of $408.0 million during Q1 2021.
  • Over the past 5 years, Moderna's median Other Gross PP&E Adjustments value was $1.7 billion (recorded in 2023), while the average stood at $1.5 billion.
  • Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first skyrocketed by 20068.03% in 2021, then tumbled by 517.24% in 2024.
  • Moderna's Other Gross PP&E Adjustments (Quarter) stood at $884.0 million in 2021, then surged by 64.93% to $1.5 billion in 2022, then rose by 6.58% to $1.6 billion in 2023, then rose by 17.95% to $1.8 billion in 2024, then grew by 12.33% to $2.1 billion in 2025.
  • Its Other Gross PP&E Adjustments was $2.1 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $2.0 billion in Q1 2025.